Literature DB >> 23053969

G241R and K469E polymorphisms of intercellular adhesion molecule 1 (ICAM-1) could predispose to Hashimoto thyroiditis.

Fevziye Emin Akman1, Müge Kanmaz-Özer, Pervin Vural, Ayşenur Özderya, Berrin Karadağ, Semra Doğru-Abbasoğlu, Müjdat Uysal.   

Abstract

This study examined firstly the possible association of G241R and K469E single nucleotide polymorphisms (SNPs) of ICAM-1 gene with the occurrence of Hashimoto thyroiditis (HT). G241R and K469E SNPs in DNA from peripheral blood leukocytes of 190 HT and 247 healthy controls were investigated by real-time PCR combined with melting curve analysis using fluorescence-labeled hybridization probes. There was a significant increase of ICAM-1 241R allele frequency in patients with HT compared with healthy controls (P = 0.04, OR = 1.84, 95 % CI = 1.00-3.37). Regarding ICAM-1 K469E polymorphism, patients homozygous for E allele had 1.73-fold increased risk for developing HT according to KK homozygotes (P = 0.04, 95 % CI = 1.00-3.01). The 469E allele frequency was higher in HT patients according to controls, however the difference was at borderline significance (P = 0.05, OR = 1.30, 95 % CI = 1.00-1.70). No associations between polymorphisms and HT phenotypes were observed. We suggest that the G241R and K469E SNPs of ICAM-1 gene may be related to occurrence of HT. However, more studies with larger sample size including other loci of the ICAM-1 gene are necessary to support our findings before any definite statement can be made about the relationship between HT and ICAM-1 polymorphism.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23053969     DOI: 10.1007/s11033-012-1963-7

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  38 in total

Review 1.  Cell adhesion/signalling: biology and clinical applications.

Authors:  M W Makgoba; A Bernard; M E Sanders
Journal:  Eur J Clin Invest       Date:  1992-07       Impact factor: 4.686

2.  Association of intercellular adhesion molecule 1 polymorphisms with retinopathy in Chinese patients with Type 2 diabetes.

Authors:  L Liu; Q Yu; H Wang; S X Zhang; C Huang; X Chen
Journal:  Diabet Med       Date:  2006-06       Impact factor: 4.359

3.  Different intrathyroid expression of intercellular adhesion molecule-1 (ICAM-1) in Hashimoto's thyroiditis and Graves' disease: analysis at mRNA level and association with B7.1 costimulatory molecule.

Authors:  G Pesce; N Fiorino; A M Riccio; P Montagna; G Torre; C Salmaso; V Altrinetti; M Bagnasco
Journal:  J Endocrinol Invest       Date:  2002-03       Impact factor: 4.256

4.  Intercellular adhesion molecule-1 (ICAM-1) polymorphism is associated with diabetic retinopathy in Type 2 diabetes mellitus.

Authors:  K Kamiuchi; G Hasegawa; H Obayashi; A Kitamura; M Ishii; M Yano; T Kanatsuna; T Yoshikawa; N Nakamura
Journal:  Diabet Med       Date:  2002-05       Impact factor: 4.359

5.  Association between Gly241Arg ICAM-1 gene polymorphism and serum sICAM-1 concentration in the Stanislas cohort.

Authors:  Anne Ponthieux; Daniel Lambert; Bernard Herbeth; Suzanne Droesch; Michèle Pfister; Sophie Visvikis
Journal:  Eur J Hum Genet       Date:  2003-09       Impact factor: 4.246

6.  Intercellular adhesion molecule 1 gene associations with immunologic subsets of inflammatory bowel disease.

Authors:  H Yang; D K Vora; S R Targan; H Toyoda; A L Beaudet; J I Rotter
Journal:  Gastroenterology       Date:  1995-08       Impact factor: 22.682

7.  K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Mojca Globocnik Petrovic; Josko Osredkar; Mirna Saraga-Babić; Daniel Petrovic
Journal:  Clin Exp Ophthalmol       Date:  2008-07       Impact factor: 4.207

8.  The single nucleotide polymorphism g.1548A >G (K469E) of the ICAM-1 gene is associated with worse prognosis in non-small cell lung cancer.

Authors:  Eirini Thanopoulou; George Kotzamanis; Ioannis S Pateras; Nicholaos Ziras; Alexandros Papalambros; Theodoros Mariolis-Sapsakos; Fragiska Sigala; Elizabeth Johnson; Athanassios Kotsinas; Andreas Scorilas; Vassilis G Gorgoulis
Journal:  Tumour Biol       Date:  2012-05-06

Review 9.  Adhesion molecules and atherosclerosis.

Authors:  Stefan Blankenberg; Sandrine Barbaux; Laurence Tiret
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

10.  Intercellular adhesion molecule-1 (ICAM-1) gene polymorphisms in endometriosis.

Authors:  P Viganò; M Infantino; D Lattuada; R Lauletta; E Ponti; E Somigliana; M Vignali; A M DiBlasio
Journal:  Mol Hum Reprod       Date:  2003-01       Impact factor: 4.025

View more
  5 in total

1.  Analysis of ICAM1 gene polymorphism in Slovak multiple sclerosis patients.

Authors:  Ivana Shawkatová; Juraj Javor; Zuzana Párnická; Mária Bucová; Daniela Čopíková-Cudráková; Jozef Michalík; Karin Gmitterová; Daniel Čierny; Milan Buc; Vladimíra Ďurmanová
Journal:  Folia Microbiol (Praha)       Date:  2017-01-27       Impact factor: 2.099

Review 2.  ICAM-1 molecular mechanism and genome wide SNP's association studies.

Authors:  C Anbarasan; M Bavanilatha; K Latchumanadhas; S Ajit Mullasari
Journal:  Indian Heart J       Date:  2015-05-16

3.  ICAM1 K469E and E-selectin S128R polymorphisms could predispose to increased autoantibody production and TSH suppression in Graves' disease.

Authors:  Müge Kanmaz-Özer; Semra Doğru-Abbasoğlu; Pervin Vural; Ayşenur Özderya; Berrin Karadağ; Müjdat Uysal
Journal:  Mol Biol Rep       Date:  2012-12-16       Impact factor: 2.316

4.  Cytotoxic T-lymphocyte associated antigen 4 polymorphism and Hashimoto's thyroiditis susceptibility: a meta-analysis.

Authors:  Hao Qiu; Weifeng Tang; Pengfei Yin; Feng Cheng; Lixin Wang
Journal:  Endocrine       Date:  2013-05-16       Impact factor: 3.633

5.  Emerging trends and hot spots in autoimmune thyroiditis research from 2000 to 2022: A bibliometric analysis.

Authors:  Qiuxian Li; Wanyu Yang; Jiashu Li; Zhongyan Shan
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.